NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
N/A (NSE: EMCURE)
EMCURE Technical Analysis
5
As on 18th Mar 2025 EMCURE SHARE Price closed @ 937.55 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 962.38 & Strong Sell for SHORT-TERM with Stoploss of 1180.18 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EMCURESHARE Price
Open | 938.00 | Change | Price | % |
High | 946.00 | 1 Day | 12.00 | 1.30 |
Low | 923.30 | 1 Week | -7.95 | -0.84 |
Close | 937.55 | 1 Month | -48.00 | -4.87 |
Volume | 63268 | 1 Year | -424.90 | -31.19 |
52 Week High 1526.60 | 52 Week Low 925.55 |
NSE N/A Most Active Stocks
NSE N/A Top Gainers Stocks
UTTAMSUGAR | 230.90 | 20.00% |
TTL | 12.67 | 19.98% |
TTL | 12.67 | 19.98% |
SINDHUTRAD | 15.99 | 19.95% |
GULPOLY | 182.49 | 17.32% |
TALBROAUTO | 246.71 | 16.13% |
RAYMOND | 1428.30 | 15.99% |
MASTEK | 2440.05 | 15.47% |
CENTUM | 1548.10 | 15.37% |
INDOAMIN | 122.76 | 15.05% |
NSE N/A Top Losers Stocks
NACLIND | 100.17 | -9.63% |
PASUPTAC | 53.05 | -7.87% |
TECILCHEM | 21.22 | -6.81% |
CASTROLIND | 222.03 | -5.93% |
SHIVALIK | 577.70 | -5.62% |
POWERINDIA | 11954.00 | -5.60% |
KARMAENG | 53.49 | -5.34% |
RPPL | 21.22 | -5.31% |
GLFL | 4.41 | -5.16% |
JPASSOCIAT | 3.49 | -5.16% |
EMCURE Daily Charts |
EMCURE Intraday Charts |
Whats New @ Bazaartrend |
EMCURE Free Analysis |
|
EMCURE Important Levels Intraday
RESISTANCE | 981.29 |
RESISTANCE | 967.26 |
RESISTANCE | 958.59 |
RESISTANCE | 949.92 |
SUPPORT | 925.18 |
SUPPORT | 916.51 |
SUPPORT | 907.84 |
SUPPORT | 893.81 |
EMCURE Target March 2025
4th UP Target | 1964.9 |
3rd UP Target | 1728.73 |
2nd UP Target | 1582.75 |
1st UP Target | 1436.77 |
1st DOWN Target | 1020.23 |
2nd DOWN Target | 874.25 |
3rd DOWN Target | 728.27 |
4th DOWN Target | 492.1 |
EMCURE Weekly Target
4th UP Target | 1083.21 |
3rd UP Target | 1033.34 |
2nd UP Target | 1002.51 |
1st UP Target | 971.68 |
1st DOWN Target | 883.72 |
2nd DOWN Target | 852.89 |
3rd DOWN Target | 822.06 |
4th DOWN Target | 772.19 |
EMCURE Target2025
4th UP Target | 2131.19 |
3rd UP Target | 1911.8 |
2nd UP Target | 1776.19 |
1st UP Target | 1640.58 |
1st DOWN Target | 1253.63 |
2nd DOWN Target | 1118.02 |
3rd DOWN Target | 982.41 |
4th DOWN Target | 763.02 |
N/A ( NSE N/A Symbol : EMCURE )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
EMCURE Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
EMCURE Other Details
Segment | N/A | |
Market Capital | N/A | |
Sector | N/A | |
Industry | N/A | |
Offical website | > echo $website ; ?> |
EMCURE Address
![]() |
N/A |
EMCURE Latest News
EMCURE Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service